Analgesics (Pharmacies) - Uzbekistan

  • Uzbekistan
  • Revenue in the Analgesics market is projected to reach US$99.27m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 15.16%, resulting in a market volume of US$201.10m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.78 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Uzbekistan is experiencing significant growth and development due to several factors.

Customer preferences:
Customers in Uzbekistan have shown a growing preference for analgesics purchased from pharmacies. This can be attributed to the increasing awareness and importance of self-medication among the population. As people become more health-conscious and seek quick relief from pain, they are turning to pharmacies for over-the-counter analgesics. Additionally, the convenience of purchasing these products from pharmacies, which are easily accessible and offer a wide range of options, is also driving customer preferences.

Trends in the market:
One of the key trends in the Analgesics (Pharmacies) market in Uzbekistan is the increasing demand for non-steroidal anti-inflammatory drugs (NSAIDs). These drugs are commonly used to relieve pain and reduce inflammation, making them a popular choice among consumers. The market is also witnessing a shift towards natural and herbal analgesics, as people are becoming more conscious of the potential side effects of synthetic drugs. This trend is in line with the global movement towards natural and organic products.

Local special circumstances:
Uzbekistan has a rapidly growing population, with a significant portion of the population being young and working professionals. This demographic trend is driving the demand for analgesics, as young individuals are more prone to injuries and muscular pain due to their active lifestyles. Furthermore, the country's healthcare system is still developing, and access to quality healthcare services may be limited in certain areas. As a result, people rely on pharmacies for immediate relief from pain, making the Analgesics (Pharmacies) market an essential part of the healthcare landscape.

Underlying macroeconomic factors:
The growing economy of Uzbekistan is also contributing to the development of the Analgesics (Pharmacies) market. As disposable incomes rise and the middle class expands, people have more purchasing power to spend on healthcare products. This increased affordability is driving the demand for analgesics, as consumers are willing to invest in their well-being and seek effective pain relief solutions. Additionally, the government's focus on improving healthcare infrastructure and accessibility is also creating a favorable environment for the growth of the Analgesics (Pharmacies) market. In conclusion, the Analgesics (Pharmacies) market in Uzbekistan is witnessing significant growth and development due to customer preferences for self-medication, the increasing demand for NSAIDs and natural analgesics, the local special circumstances of a young and active population, and the underlying macroeconomic factors of a growing economy and government support for healthcare. This market is expected to continue its upward trajectory as the population becomes more health-conscious and the healthcare infrastructure further improves.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)